Profound Medical Corp. | Mutual Funds
Mutual Funds that own Profound Medical Corp.
Fidelity True North Fund
6,200,000
5.74%
25,000
0.12%
07/31/2018
Galileo High Income Plus Fund
400,000
0.37%
400,000
0.78%
06/30/2018
Front Street Global Opportunities Class
210,000
0.19%
0
0.25%
06/29/2018
Exemplar Leaders Fund
187,400
0.17%
187,400
0.44%
06/30/2018
90,000
0.08%
0
0.22%
06/28/2018
| Address |
2400 Skymark Avenue
Mississauga Ontario L4W 5K5
Canada
|
|
Employees
|
- |
| Website |
http://www.profoundmedical.com |
| Updated |
07/08/2019 |
| Profound Medical Corp. engages in developing and commercializing minimally invasive treatments for prostate cancer. It develops Transurethral Ultrasound Ablation-PRO system that completed a Phase I clinical trial, which combines magnetic resonance imaging guidance, and ultrasound energy to deliver thermal ablative therapy to the prostate gland delivered through the urethra. Profound Medical was founded in 2008 and is headquartered in Toronto, CA. |
